U.S. Food and Drug Administration (FDA) allows advancement of RAP-219 into registrational trials for focal onset seizures (FOS); accelerated initiation of Phase 3 program expected in the second ...
Bright Minds Biosciences (DRUG) stays a Strong Buy after Phase 2 BMB-101 seizure-reduction data; see 2026 catalysts, ...
An Horry County Circuit Court judge plans to decide this week whether to dismiss a wrongful death lawsuit against a Myrtle Beach-based kratom company.
Doncaster Free Press on MSN
Doncaster man, 31, almost dies after 'running injury' turns out to be a sign of deadly brain cancer
A man's 'running injury' turned out to be a sign of deadly cancer. Sean Ryan Sweeney, aged 31, began experiencing frequent ...
The man accused of driving the dump truck that ran a stop sign, hitting and killing four workers, appeared in court on ...
The field of epilepsy research has rapidly evolved with an appreciation that seizures arise from dysfunctions in distributed ...
News-Medical.Net on MSN
Gene therapy breakthrough could provide hope for millions living with chronic pain
A preclinical study uncovered a new gene therapy that targets pain centers in the brain while eliminating the risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback